KEVIN BOYTER: Open Payments
NPI 1326111998 · SPARTANBURG, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$683 in 25 payments from 9 companies in 2025. Trend: 2023 $731 · 2024 $1,154 · 2025 $683
Food & beverage: $683
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $386 |
| Novo Nordisk Inc | 5 | $75 |
| ABBVIE INC. | 4 | $57 |
| Amgen Inc. | 3 | $45 |
| PFIZER INC. | 2 | $38 |
| Abbott Laboratories | 2 | $38 |
| Antares Pharma, Inc. | 1 | $15 |
| Corium, LLC | 1 | $14 |
| SANOFI-AVENTIS U.S. LLC | 1 | $14 |
Products named: BREZTRI, AIRSUPRA, FARXIGA, Rybelsus, NURTEC ODT, FREESTYLE LIBRE 3, OTEZLA, VRAYLAR.
Industry payments across SC — which companies pay providers there.
